|
China Literature Limited (0772.HK) Avaliação DCF |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
China Literature Limited (0772.HK) Bundle
Explore as perspectivas financeiras da China Literature Limited (0772HK) com nossa calculadora DCF amigável! Digite suas suposições sobre crescimento, margens e despesas para determinar o valor intrínseco da China Literature Limited (0772HK) e informe suas decisões de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,306.5 | 9,462.1 | 8,324.0 | 7,654.0 | 8,864.8 | 8,807.5 | 8,750.6 | 8,694.1 | 8,637.9 | 8,582.0 |
| Revenue Growth, % | 0 | 1.67 | -12.03 | -8.05 | 15.82 | -0.64634 | -0.64634 | -0.64634 | -0.64634 | -0.64634 |
| EBITDA | -2,863.0 | 1,908.6 | 1,309.5 | 1,330.7 | 816.9 | 559.1 | 555.5 | 551.9 | 548.3 | 544.8 |
| EBITDA, % | -30.76 | 20.17 | 15.73 | 17.39 | 9.21 | 6.35 | 6.35 | 6.35 | 6.35 | 6.35 |
| Depreciation | 329.6 | 540.1 | 412.3 | 325.3 | 204.6 | 365.7 | 363.3 | 361.0 | 358.7 | 356.3 |
| Depreciation, % | 3.54 | 5.71 | 4.95 | 4.25 | 2.31 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 |
| EBIT | -3,192.6 | 1,368.4 | 897.2 | 1,005.4 | 612.3 | 193.4 | 192.1 | 190.9 | 189.7 | 188.4 |
| EBIT, % | -34.3 | 14.46 | 10.78 | 13.14 | 6.91 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 |
| Total Cash | 6,829.9 | 7,866.4 | 8,201.9 | 6,858.7 | 8,321.4 | 7,724.9 | 7,675.0 | 7,625.4 | 7,576.1 | 7,527.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,598.2 | 2,998.8 | 2,236.6 | 2,170.3 | 2,361.9 | 2,681.4 | 2,664.1 | 2,646.9 | 2,629.8 | 2,612.8 |
| Account Receivables, % | 38.66 | 31.69 | 26.87 | 28.36 | 26.64 | 30.44 | 30.44 | 30.44 | 30.44 | 30.44 |
| Inventories | 624.2 | 713.6 | 829.9 | 811.8 | 756.5 | 763.8 | 758.8 | 753.9 | 749.1 | 744.2 |
| Inventories, % | 6.71 | 7.54 | 9.97 | 10.61 | 8.53 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 |
| Accounts Payable | 1,134.9 | 1,230.6 | 1,314.1 | 1,222.3 | 1,140.3 | 1,229.9 | 1,221.9 | 1,214.0 | 1,206.2 | 1,198.4 |
| Accounts Payable, % | 12.19 | 13.01 | 15.79 | 15.97 | 12.86 | 13.96 | 13.96 | 13.96 | 13.96 | 13.96 |
| Capital Expenditure | -314.7 | -261.0 | -353.3 | -193.6 | -128.6 | -253.0 | -251.4 | -249.8 | -248.2 | -246.6 |
| Capital Expenditure, % | -3.38 | -2.76 | -4.24 | -2.53 | -1.45 | -2.87 | -2.87 | -2.87 | -2.87 | -2.87 |
| Tax Rate, % | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 | -111.49 |
| EBITAT | -3,165.5 | 1,097.2 | 705.1 | 897.8 | 1,294.9 | 173.0 | 171.9 | 170.7 | 169.6 | 168.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6,238.1 | 1,982.0 | 1,493.7 | 1,022.0 | 1,152.6 | 48.5 | 298.1 | 296.2 | 294.3 | 292.4 |
| WACC, % | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 | 7.21 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 974.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 298 | |||||||||
| Terminal Value | 5,726 | |||||||||
| Present Terminal Value | 4,043 | |||||||||
| Enterprise Value | 5,017 | |||||||||
| Net Debt | -3,382 | |||||||||
| Equity Value | 8,399 | |||||||||
| Diluted Shares Outstanding, MM | 1,013 | |||||||||
| Equity Value Per Share | 8.29 |
What You Will Receive
- Pre-Filled Financial Model: Utilizing China Literature Limited’s actual data for accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates allow you to view results immediately as adjustments are made.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuations.
- Customizable and Reusable: Designed for flexibility, making it suitable for ongoing detailed forecasts.
Key Features
- 🔍 Real-Life China Literature Financials: Pre-filled historical and projected data for China Literature Limited (0772HK).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate China Literature’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize China Literature’s valuation instantly after making adjustments.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review China Literature Limited’s (0772HK) pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and apply the results to inform your investment decisions.
Why Opt for This Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio assessments in a single tool.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different scenarios.
- In-Depth Analysis: Automatically determines China Literature Limited’s intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable starting points.
- Professional Standard: Perfect for financial analysts, investors, and business consultants.
Who Can Benefit from This Product?
- Individual Investors: Make well-informed choices regarding the purchase or sale of China Literature Limited (0772HK) shares.
- Financial Analysts: Enhance valuation workflows with pre-built financial models tailored for China Literature Limited (0772HK).
- Consultants: Provide clients with precise and timely valuation insights on China Literature Limited (0772HK).
- Business Owners: Gain insights into how major firms like China Literature Limited (0772HK) are valued to shape your own business strategies.
- Finance Students: Acquire practical knowledge in valuation techniques using real-world data and case studies involving China Literature Limited (0772HK).
What the Template Includes
- Preloaded 0772HK Data: Historical and forecasted financial information, encompassing revenue, EBIT, and capital expenditures.
- DCF and WACC Models: High-quality spreadsheets designed for computing intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Cells highlighted in yellow for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial statements for in-depth analysis.
- Key Ratios: Ratios for profitability, leverage, and efficiency to assess performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.